Actualités
Pour les spécialistes
Enseignement – Recherche – Collaboration interdisciplinaire
Pour une prise en charge excellente et globale des patients atteints de vascularites.
Les vascularites sont des maladies systémiques complexes qui nécessitent une collaboration interdisciplinaire. La VASAS met en réseau des spécialistes issus du milieu hospitalier et de la recherche afin de partager les connaissances, de faire avancer la recherche et d'améliorer et de garantir durablement la prise en charge des patients.
Vos avantages en tant que membre :
- Formation postgraduée et continue: Formations et offres de formation continue sur des thèmes spécifiques, axées sur les développements actuels et les nouvelles thérapies.
- Discussions de cas interactives: conférences de cas mensuelles basées sur le web pour l'échange professionnel et la discussion de cas complexes et instructifs.
- Réseau scientifique: Journée scientifique annuelle de l'AASV pour l'échange clinique et scientifique.
- Recherche [& ;] Travail de registre : Participation à des études et des registres tels que l'étude multicentrique sur l'artérite de Takayasu et la mise en place du registre ANCA.
- Contribuer à l'élaboration des normes: Développer des recommandations pratiques sur le diagnostic, le traitement et le suivi de la maladie.
- Soutien au quotidien: Aide pour les demandes de garantie de prise en charge des coûts, accès à des modèles standardisés et conseil collégial personnel.
- Espace réservé aux membres: Accès à des matériaux, des outils, des protocoles d'étude et plus encore.
Discussion de cas
Discussions de cas régulières sur le web.
Toutes les 4 à 6 semaines
le mercredi à 17h
Valeur ajoutée en tant que membre VASAS
Rejoignez un réseau engagé
pour des bases décisionnelles solides, des échanges animés dans le domaine de la recherche et de la clinique et une collaboration interdisciplinaire pour une prise en charge optimale de vos patients.
Publications sur le thème de la vascularite par les membres de l'AFS - 2024 / 25
- Christ L, Bonel HM, Cullmann JL, Seitz L, Bütikofer L, Wagner F, Villiger PM. Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab. Rheumatology (Oxford). 2025 Apr 1;64(4):2059-2067. doi: 10.1093/rheumatology/keae378. PMID: 39037916.
- Mattioli I, Urban ML, Padoan R, Mohammad AJ, Salvarani C, Baldini C, Berti A, Cameli P, Caminati M, Cathébras P, Bianchi FC, Cinetto F, Cohen Tervaert JW, Coppola A, Costanzo G, Cottin V, Crimi C, Del Giacco S, Desaintjean C, Egan A, Espigol-Frigolé G, Folci M, Fornaro M, Franceschini F, Govoni M, Groh M, Guarnieri G, Hellmich B, Iannone F, Jones R, Kernder A, Lo Gullo A, Lombardi C, Lopalco G, Losappio L, Marchi MR, Rivera CM, Marvisi C, Maule M, Moi L, Monti S, Moosig F, Moroncini G, Negrini SM, Neumann T, Nolasco S, Novikov P, Roccatello D, Samson M, Schroeder JW, Seeliger B, Sinico RA, Solans R, Tcherakian C, Toniati P, Treppo E, Trivioli G, Vacca A, Jayne D, Bettiol A, Vaglio A, Emmi G; European EGPA Study Group. Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study. J Autoimmun. 2025 Mar 26;153:103398. doi: 10.1016/j.jaut.2025.103398. Epub ahead of print. PMID: 40147217.
- Schremmer T, Dejaco C, Recker F, Aschwanden M, Boumans D, Bruyn GA, Chrysidis S, Daikeler T, Nielsen B, De Miguel E, Diamantopoulos AP, Dohn UM, Duftner C, Germano G, Haagsma C, Hartung W, Hocevar A, Iagnocco A, Juche A, Karakostas P, Karalilova R, Keller KK, Sarker B, Smith K, Tischler V, Macchioni P, Milchert M, Monti S, Mukhtyar C, Naredo E, Schmidt WA, Seitz L, Terslev L, Wakefield RJ, Schäfer VS. OMERACT GCA phantom project: validation of a 3D-printed ultrasound training phantom for diagnosis of giant cell arteritis. RMD Open. 2025 Feb 6;11(1):e005316. doi: 10.1136/rmdopen-2024-005316. PMID: 39915246; PMCID: PMC11804187.
- Seitz P, Cullmann J, Bucher S, Bütikofer L, Reichenbach S, Lötscher F, Amsler J, Christ L, Bonel HM, Villiger PM, Seitz L. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford). 2025 Jan 1;64(1):321-331. doi: 10.1093/rheumatology/keae043. PMID: 38265241.
- Pernet M, Moi L, Serra F, Garin N. Oral and Intestinal Manifestations of Giant Cell Arteritis. Eur J Case Rep Intern Med. 2025 Jan 7;12(2):005081. doi: 10.12890/2025_005081. PMID: 39926577; PMCID: PMC11801502.
- Pesce E, Bombaci M, Croci S, Bonacini M, Marvisi C, Ricordi C, Monti S, Muratore F, Abrignani S, Caporali R, Borghi MO, Salvarani C, Villiger PM, Grifantini R, Meroni PL. Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis. Clin Exp Rheumatol. 2024 Jul;42(7):1317-1320. doi: 10.55563/clinexprheumatol/0213qf. Epub 2024 Jun 28. PMID: 38976303.
- Zingg F, Ryser FS, Gloor AD, Polysopoulos C, Villiger PM, Maurer B, Christ L. Serum protein profiling reveals distinct patient clusters in giant cell arteritis. Rheumatology (Oxford). 2024 Oct 1;63(10):2887-2896. doi: 10.1093/rheumatology/keae072. PMID: 38323660.
- Seitz P, Cullmann J, Bucher S, Bütikofer L, Reichenbach S, Lötscher F, Amsler J, Christ L, Bonel HM, Villiger PM, Seitz L. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford). 2025 Jan 1;64(1):321-331. doi: 10.1093/rheumatology/keae043. PMID: 38265241.
- Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. PMID: 38393328.
- Arnold S, Wallmeier P, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Petersen J, Reichelt de Tenorio A, Schaier M, Schirmer JH, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Iking-Konert C, Lamprecht P. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patients. Clin Exp Rheumatol. 2024 Apr;42(4):852-858. doi: 10.55563/clinexprheumatol/suxkyq. Epub 2024 Apr 12. PMID: 38607682.
- Wallmeier P, Arnold S, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Schaier M, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Petersen J, Lamprecht P, Iking-Konert C. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients. Clin Exp Rheumatol. 2024 Apr;42(4):895-904. doi: 10.55563/clinexprheumatol/d3o0gu. Epub 2024 Apr 19. PMID: 38683207.
- Hoffmann A, Almiri W, Mordasini P, Bähler A, Seiffge DJ, Göldlin MB, Jäger E, Muresan IP, Christ L, Heldner MR, Wiest R, Radojewski P. 7T MRI as a powerful tool to detect small and medium size vessel CNS vasculitis. AJNR Am J Neuroradiol. 2024 Dec 18:ajnr.A8627. doi: 10.3174/ajnr.A8627. Epub ahead of print. PMID: 39694614.
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. PMID: 39549485.
- Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z, Jayne D, Wester-Trejo M, Wallquist C, Westman K. Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2024 Aug 30;39(9):1483-1493. doi: 10.1093/ndt/gfae018. Erratum in: Nephrol Dial Transplant. 2024 Sep 19:gfae201. doi: 10.1093/ndt/gfae201. PMID: 38268409; PMCID: PMC11361807.
- Bettiol A, Urban ML, Padoan R, Groh M, Lopalco G, Egan A, Cottin V, Fraticelli P, Crimi C, Del Giacco S, Losappio L, Moi L, Cinetto F, Caminati M, Novikov P, Berti A, Cameli P, Cathébras P, Coppola A, Durel CA, Folci M, Lo Gullo A, Lombardi C, Monti S, Parronchi P, Rivera CM, Solans R, Vacca A, Espígol-Frigolé G, Guarnieri G, Bianchi FC, Marchi MR, Tcherakian C, Kahn JE, Iannone F, Venerito V, Desaintjean C, Moroncini G, Nolasco S, Costanzo GAML, Schroeder JW, Ribi C, Tesi M, Gelain E, Mattioli I, Bello F, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study. Lancet Rheumatol. 2023 Dec;5(12):e707-e715. doi: 10.1016/S2665-9913(23)00243-6. Epub 2023 Nov 6. PMID: 38251561.
- Krämer S, Vogt K, Schreibing TM, Busch M, Schmitt T, Bergner R, Mosberger S, Neumann T, Rauen T. Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort. Rheumatol Int. 2024 Dec 24;45(1):7. doi: 10.1007/s00296-024-05757-4. PMID: 39718586; PMCID: PMC11668861.
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. PMID: 39549485.
- Joos L, Gonzalez Chiappe S, Neumann T, Mahr A. Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners. Rheumatol Int. 2024 Dec;44(12):3099-3106. doi: 10.1007/s00296-024-05620-6. Epub 2024 Jun 27. PMID: 38935122.
- Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford CA, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Daikeler T, Berger CT, Molloy ES, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel PA, Cid MC, González-Gay MA, Morgan AW, Martin J, Márquez A; Spanish GCA Group; UK GCA Consortium; Vasculitis Clinical Research Consortium. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. Lancet Rheumatol. 2024 Jun;6(6):e374-e383. doi: 10.1016/S2665-9913(24)00064-X. Epub 2024 May 8. PMID: 38734017; PMCID: PMC11108802.
- Geraldes R, Santos M, Ponte C, Craven A, Barra L, Robson JC, Hammam N, Springer J, Henes J, Hocevar A, Putaala J, Santos E, Rajasekhar L, Daikeler T, Karadag O, Costa A, Khalidi N, Pagnoux C, Canhão P, Melo TPE, Fonseca AC, Ferro JM, Fonseca JE, Suppiah R, Watts RA, Grayson P, Merkel PA, Luqmani RA; DCVAS Study Group. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study. J Neurol. 2024 Jun;271(6):3309-3320. doi: 10.1007/s00415-024-12251-1. Epub 2024 Mar 12. PMID: 38472397; PMCID: PMC11136713.
- Hemmig AK, Rottenburger C, Baruti L, Mensch N, Aschwanden M, Kyburz D, Pradella M, Staub D, Stegert M, Berger CT, Imfeld S, Sommer G, Daikeler T. Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis - A cohort study. Semin Arthritis Rheum. 2024 Jun;66:152425. doi: 10.1016/j.semarthrit.2024.152425. Epub 2024 Feb 28. PMID: 38442463.
- Borrego-Yaniz, Ortiz-Fernández, Madrid-Paredes, Kerick, Hernández-Rodríguez, Mackie, Vaglio, Castañeda, Solans, Mestre, Khalidi, Langford, Ytterberg, Beretta, Govoni, Emmi, Cimmino, Witte, Neumann, Holle, Schönau, Puignet, Papo, Haroche, Mahr, Mouthon, Molberg, Diamantopoulos, Voskuyl, Daikeler, Berger, Molloy, Blockmans, Iles, Sorensen, Luqmani, Reynolds, Bukhari, Bhagat, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium, Ortego-Centeno, Brouwer, Lamprecht, Kapla, Salvarani, Merkel, Cid, González-Gay, Morgan, Martin, Marquez, Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study, Lancet Rheumatology, Volume 6, Issue 6, June 2024, Pages e374-e383
- Joos L, Gonzalez Chiappe S, Neumann T, Mahr A, Use of Mesna Prophylaxis in Patients with Cyclophosphamide-Treated ANCA-associated Vasculitis: Cross-Sectional Survey of Practitioners, Rheumatology International 2024
- Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R and Terrier B, on behalf of the French Vasculitis Study Group (FVSG) and the European EGPA Study Group (EESG), Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis, factor: a target trial emulation study, J Autoimmun. 2024
